IN2012MN02476A - - Google Patents
Info
- Publication number
- IN2012MN02476A IN2012MN02476A IN2476MUN2012A IN2012MN02476A IN 2012MN02476 A IN2012MN02476 A IN 2012MN02476A IN 2476MUN2012 A IN2476MUN2012 A IN 2476MUN2012A IN 2012MN02476 A IN2012MN02476 A IN 2012MN02476A
- Authority
- IN
- India
- Prior art keywords
- diet
- compositions
- health management
- human
- dietary health
- Prior art date
Links
- 235000005911 diet Nutrition 0.000 abstract 3
- 230000037213 diet Effects 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 235000005118 dietary health Nutrition 0.000 abstract 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 abstract 2
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 206010012735 Diarrhoea Diseases 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000000835 fiber Substances 0.000 abstract 1
- 229940074391 gallic acid Drugs 0.000 abstract 1
- 235000004515 gallic acid Nutrition 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000008101 lactose Substances 0.000 abstract 1
- 150000008442 polyphenolic compounds Chemical class 0.000 abstract 1
- 235000013824 polyphenols Nutrition 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 239000008107 starch Substances 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Pediatric Medicine (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
This invention relates to a plurality of compositions for dietary health management and its use in the prevention or treatment of any one of the disease states in the group consisting of cardiovascular disease, inflammation and diarrhoea. Human evolution has been a very slow process in contrast to the relatively recent, rapid changes in our diet since the Neolithic revolution which marked the switch from hunter-gatherer to agricultural life-style around 10,000 years ago. Moreover our genome has not had time to evolve at the same pace and therefore it is postulated that our bodies will work more efficiently with an ancestral diet. In a first aspect of the invention, a plurality of compositions for the dietary health management system of a human being is provided, wherein the plurality of compositions comprise a daily diet of: (g) 1750 to 2750 kilocalories (7350 to 11550 kiloJoules); (h) have more than 1250, preferably more than 1450, more preferably more than 1650 mg gallic acid equivalents of polyphenols; (i) have more than 40, preferably more than 50, more preferably more than 60 g fibre; (j) have more than 130, preferably more than 150, more preferably more than 170 g protein (k) have 0 to 2, preferably 0 to 1.5, most preferably 0 to 1 g starch; and (I) have 0 to 5, preferably 0 to 2.5, most preferably 0 to 1 g lactose.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10164261 | 2010-05-28 | ||
| PCT/EP2011/058537 WO2011147862A1 (en) | 2010-05-28 | 2011-05-25 | Compositions for dietary health management |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012MN02476A true IN2012MN02476A (en) | 2015-06-12 |
Family
ID=43422235
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN2476MUN2012 IN2012MN02476A (en) | 2010-05-28 | 2011-05-25 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9451785B2 (en) |
| EP (1) | EP2575500B1 (en) |
| CN (1) | CN102970882B (en) |
| BR (1) | BR112012030117A2 (en) |
| IN (1) | IN2012MN02476A (en) |
| WO (1) | WO2011147862A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013079536A1 (en) * | 2011-11-29 | 2013-06-06 | Unilever Plc | A meal intended for human consumption |
| KR101618969B1 (en) | 2014-08-26 | 2016-05-09 | 원광대학교산학협력단 | Pharmaceutical composition comprising compounds for inhibiting differentiation and formation of osteoclast |
| KR101797454B1 (en) | 2016-07-06 | 2017-11-15 | 원광대학교산학협력단 | A pharmaceutical composition for promoting bone formation, comprising Cyanidin-3-glucoside or a pharmaceutically acceptable salt thereof |
| CN111096972B (en) * | 2020-02-25 | 2023-07-14 | 成都医学院 | A pharmaceutical composition for preventing and/or treating Alzheimer's disease |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2222176A1 (en) | 1995-06-06 | 1996-12-12 | Campbell Soup Company | Compliance support package for increasing health management system compliance |
| EP0833570A1 (en) | 1995-06-06 | 1998-04-08 | Campbell Soup Company | Therapeutic system for dietary health management |
| US6039989A (en) | 1995-06-06 | 2000-03-21 | Campbell Soup Company | Prepackaged therapeutic meal for treatment of diet-responsive conditions |
| US6352712B1 (en) | 1999-04-30 | 2002-03-05 | Daniel O. Lukaczer | Dietary supplements for treating fatigue-related syndromes |
| WO2002011562A2 (en) | 2000-08-08 | 2002-02-14 | Advanced Functional Foods International, Inc. | Nutritional supplement for the management of weight |
| US6808727B2 (en) | 2001-07-20 | 2004-10-26 | Emanuel S. Kemeny | Meal-equivalent food bar |
| US20030206982A1 (en) | 2002-04-24 | 2003-11-06 | Antje Spors | Method of improving dietary balance using gustatory and olfactory aliesthesia |
| JP2004242586A (en) | 2003-02-14 | 2004-09-02 | Eifuji:Kk | Processed foods, by-products of processed foods or methods for producing juices |
| WO2006026471A2 (en) | 2004-08-25 | 2006-03-09 | Regents Of The University Of Minnesota | Compositions and methods to lower glycohemoglobin levels |
| CN101305802B (en) | 2008-07-07 | 2014-03-12 | 杭州名博健康管理有限公司 | Diet intervention products |
-
2011
- 2011-05-25 EP EP11721324.9A patent/EP2575500B1/en not_active Not-in-force
- 2011-05-25 CN CN201180026011.1A patent/CN102970882B/en not_active Expired - Fee Related
- 2011-05-25 US US13/698,685 patent/US9451785B2/en not_active Expired - Fee Related
- 2011-05-25 WO PCT/EP2011/058537 patent/WO2011147862A1/en not_active Ceased
- 2011-05-25 BR BR112012030117A patent/BR112012030117A2/en not_active IP Right Cessation
- 2011-05-25 IN IN2476MUN2012 patent/IN2012MN02476A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112012030117A2 (en) | 2017-05-16 |
| EP2575500A1 (en) | 2013-04-10 |
| US9451785B2 (en) | 2016-09-27 |
| US20140057843A1 (en) | 2014-02-27 |
| CN102970882A (en) | 2013-03-13 |
| EP2575500B1 (en) | 2014-05-14 |
| CN102970882B (en) | 2015-07-22 |
| WO2011147862A1 (en) | 2011-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Mozaffarian et al. | History of modern nutrition science—implications for current research, dietary guidelines, and food policy | |
| SA522432741B1 (en) | Benzothia(di)azepine compounds and their use as bile acid modifiers | |
| WO2019066577A3 (en) | Composition for diagnosis and treatment of alcoholic liver disease, using change in short-chain fatty acid producing gut bacterial community | |
| MX2012007232A (en) | Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis. | |
| MX2009006342A (en) | Nutritional supplement composition for treatment of ocular diseases. | |
| Nguyen et al. | Matrix metalloproteinases (MMPs) inhibitory effects of an octameric oligopeptide isolated from abalone Haliotis discus hannai | |
| MX2014004722A (en) | Composition for use in the promotion of healthy bone growth and/or in the prevention and/or treatment of bone disease. | |
| EA201070893A1 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF BONE DISEASES | |
| IN2012MN02476A (en) | ||
| WO2006108582A3 (en) | Human marker genes and agents for diagnosis, treatment and prophylaxis of cardiovascular disorders and artherosclerosis | |
| WO2011077163A3 (en) | Use | |
| BR112019019405A2 (en) | use of a composition, antimicrobial composition, use or composition, pharmaceutical composition and therapeutic or non-therapeutic method | |
| GB0615781D0 (en) | Prebiotic composition | |
| WO2010146078A3 (en) | Novel uses of hydroxyproline compositions | |
| MY153109A (en) | A solid pharmaceutical formulation | |
| IN2014MN00932A (en) | ||
| WO2011031166A3 (en) | Fish feed | |
| MX2023009342A (en) | Compositions and methods using a combination of oleuropein and magnesium. | |
| WO2016027225A8 (en) | A composition having a muscle-relaxant and anti-inflammatory activity | |
| PH12013500451A1 (en) | Sphaeranthus indicus derived ingredients and their compositions for enhancing physical performance and energy levels | |
| GEP20084412B (en) | Medical-preventive food combination and foodstuff on its base | |
| WO2009108067A3 (en) | Fatty acid derivatives for use in the prevention and treatment of hsmi | |
| WO2007031140A3 (en) | Extracts from epimedium species method for production and use thereof | |
| HUSSAIN et al. | HUDDA AYUB4, FAIMA ATTA KHANS | |
| CN105054000A (en) | Fruit and vegetable jelly enzyme |